![]() |
市場調査レポート
商品コード
1754079
口内炎治療市場レポート:剤形、薬剤クラス、適応症、地域別、2025-2033年Mouth Ulcer Treatment Market Report by Formulation, Drug Class, Indication, and Region 2025-2033 |
||||||
カスタマイズ可能
|
口内炎治療市場レポート:剤形、薬剤クラス、適応症、地域別、2025-2033年 |
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2~3営業日
|
口内炎治療の世界市場規模は2024年に19億7,000万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに25億5,000万米ドルに達し、2025年から2033年にかけて2.74%の成長率(CAGR)を示すと予測しています。同市場は、主に口腔衛生問題の発生率の上昇、治療オプションに対する意識の高まり、市販治療薬に対する需要の高まりによって大きな成長を遂げています。医薬製剤の進歩、ヘルスケアへのアクセスの拡大、口内炎治療のための即効性鎮痛剤に対する消費者の嗜好も市場成長にプラスに寄与しています。
製剤イノベーション
各社は、迅速な緩和と治癒を求める消費者の需要に対応するため、即効性のある口内炎治療薬を開発しています。これらのイノベーションには、痛みを最小限に抑え、数時間以内に回復を早めるように設計された局所用ジェル、口腔洗浄剤、薬用パッチなどが含まれます。先進的な製剤は、即時吸収または徐放性による標的作用の提供に重点を置いており、効果が長時間持続します。この動向は、消費者の利便性への期待に後押しされたもので、塗布が容易でありながら迅速な緩和をもたらす製品が求められています。処方箋を必要としない迅速な治療が高く評価される多忙なライフスタイルにおいても、こうした迅速な解決策は魅力的です。さらに、2024年のEuropean Journal of Pharmaceutics and Biopharmaceutics誌に掲載された論文によると、革新的なオイゲノールとホウ砂をベースとした口腔内分散性フィルム(ODF)の開発は、口内炎を含む口腔疾患を治療する従来の方法に代わる、はるかに効率的な結果をもたらす好ましい選択肢として浮上しています。ODFは、超薄型で、スタンプサイズで、携帯可能で、患者に優しく、親水性のフィルムであり、水や嚥下を必要とせず、舌や頬の上で数秒で溶解・崩壊します。この投与法は、特に小児、老人、嚥下障害のある特殊な患者層に普及しています。
eコマースチャネルの成長
より多くの消費者が利便性を求めてオンラインショッピングに移行しているため、口内炎治療のeコマースチャネルの成長は加速しています。オンラインプラットフォームでは、地元の薬局では手に入らないような様々な天然薬、OTC薬、特殊な治療薬など、幅広い品揃えを提供しています。消費者は、価格の比較、レビューの閲覧、製品の迅速な受け取りが容易で、多くの場合、割引や定期購入サービスが受けられるという利点があります。さらに、電子薬局やデジタルヘルスプラットフォームの台頭は、これらの治療法の入手可能性とアクセシビリティの向上に貢献し、市場におけるオンライン販売を後押ししています。例えば、IMARCによると、世界の電子薬局市場規模は2023年に942億米ドルに達しました。今後、IMARCグループは、同市場が2032年までに3,141億米ドルに達し、2024年から2032年の間に14.32%の成長率(CAGR)を示すと予測しています。さらに、アマゾンファーマシーは2024年6月、メディケア保険の加入者にも定期購入サービスを拡大する意向であることを発表しました。この拡大により、5,000万人以上のメディケア受給者がAmazon Pharmacyの定額処方サービスであるRxPassを利用できるようになります。
ナチュラル&ハーブ製品へのシフト
消費者は、合成薬の潜在的な副作用に対する懸念から、口内炎治療のために天然素材やハーブ製品にますます目を向けるようになっています。アロエベラ、カモミール、甘草のような成分は、鎮静作用や治癒作用があるとして好まれています。このような変化は、人々が健康志向のライフスタイルに沿った、オーガニックで化学物質を含まないソリューションを好むようになり、ウェルネスに広く焦点が当てられるようになったことが背景にあります。このような治療に対する需要の高まりは、この傾向に対応した植物由来の製品を開発する企業を後押しし、天然代替品が広く市場に出回るようになっています。口内炎治療市場概要によると、このような自然療法やハーブ療法に対する消費者の嗜好の高まりは、オーガニックで化学物質を含まないソリューションに対する需要の高まりに対応するため、より多くの企業が植物ベースの製剤に投資することで、大きな成長を促進すると予想されています。例えば、2023年11月、UGM歯学部の学生が口内炎治療のために果物の皮からエコ酵素を開発したと発表しました。研究チームは、さまざまな果物や植物の皮をエコ酵素に加工し、口内炎の治癒促進を目指しました。ラットを使った実験室調査では、エコ酵素パッチが口内炎の傷の炎症細胞を減少させるという有望な結果が得られました。研究は初期段階にあり、動物実験にとどまっているが、人間への使用の安全性と有効性を確保するためには、さらなる包括的な研究が必要です。
The global mouth ulcer treatment market size reached USD 1.97 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.55 Billion by 2033, exhibiting a growth rate (CAGR) of 2.74% during 2025-2033. The market is experiencing significant growth mainly driven by rising incidences of oral health issues, an increased awareness of treatment options and the growing demand for over-the-counter remedies. Advancements in pharmaceutical formulations, expanding healthcare access and consumer preference for fast-acting, pain-relief products to treat mouth ulcers are also contributing positively to the market growth.
Innovation in Formulations
Companies are developing fast-acting mouth ulcer treatments to address the consumer demand for quicker relief and healing. These innovations include topical gels, oral rinses, and medicated patches designed to minimize pain and accelerate recovery within hours. Advanced formulations focus on delivering targeted action through immediate absorption or sustained release, providing long-lasting effects. This trend is driven by consumer expectations for convenience, with products that offer swift relief while being easy to apply. These rapid solutions are also appealing in busy lifestyles where quick treatment without the need for prescriptions is highly valued. Furthermore, according to an article published in the European Journal of Pharmaceutics and Biopharmaceutics in 2024, the development of innovative eugenol and borax-based orodispersible films (ODFs) have emerged as the preferred alternative to traditional methods of treating oral diseases, including mouth ulcers, with a much more efficient results. ODFs are ultra-thin, stamp-sized, portably-used, patient-friendly, and hydrophilic films that dissolve and disintegrate within seconds on the tongue or buccal area without the need of water or swallowing. This administration is particularly prevalent among pediatric, geriatric, and special patient populations who have dysphagia.
Growth in E-Commerce Channels
Growth in e-commerce channels for mouth ulcer treatments is accelerating as more consumers shift toward online shopping for convenience. Online platforms offer a wider selection of products, including various natural, OTC, and specialized treatments, which may not be available in local pharmacies. Consumers benefit from the ease of comparing prices, reading reviews, and receiving products quickly, often with discounts or subscription services. Additionally, the rise of e-pharmacies and digital health platforms has contributed to the increased availability and accessibility of these treatments, boosting online sales in the market. For instance, according to IMARC, the global e-pharmacy market size reached US$ 94.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 314.1 Billion by 2032, exhibiting a growth rate (CAGR) of 14.32% during 2024-2032. Furthermore, Amazon Pharmacy announced in June 2024 that it intends to expand its subscription service to enrollees of Medicare insurance plans. The expansion will be available to more than 50 million Medicare beneficiaries, who will have access to RxPass, Amazon Pharmacy's subscription prescription service
Shift Towards Natural and Herbal Products
Consumers are increasingly turning to natural and herbal products for mouth ulcer treatment due to concerns about the potential side effects of synthetic medications. Ingredients like aloe vera, chamomile, and licorice are favored for their soothing and healing properties. This shift is driven by a broader focus on wellness, as people prefer organic and chemical-free solutions that align with health-conscious lifestyles. The growing demand for such treatments is encouraging companies to develop more plant-based products that cater to this trend, making natural alternatives widely available across the market. According to the mouth ulcer treatment market overview, this rising consumer preference for natural and herbal remedies is expected to drive significant growth, with more companies investing in plant-based formulations to meet the increasing demand for organic, chemical-free solutions. For instance, in November 2023, UGM Dentistry students announced the development of eco-enzymes from fruit peels for mouth ulcer treatment. The team processed peels from various fruits and plants into eco-enzymes, aiming to accelerate mouth ulcer healing. Laboratory research on rats showed promising results, with the eco-enzyme patch reducing inflammatory cells in mouth ulcer wounds. While the research is in early stages and tested only on animals, further comprehensive studies are required to ensure its safety and efficacy for human use.
Gel accounts for the majority of the market share
According to mouth ulcer treatment market report, gel dominate the market due to their fast-acting and targeted relief. Their easy application and ability to form a protective barrier over the ulcer make them highly effective in soothing pain and accelerating healing. Gels often contain active ingredients like antiseptics, pain relievers, and anti-inflammatory agents, providing comprehensive treatment in a single application. Their ability to stay localized at the site of the ulcer allows for longer-lasting relief compared to other forms, such as mouthwashes or lozenges. This convenience and effectiveness have led to their widespread preference among consumers.
Corticosteroids holds the largest share of the industry
Corticosteroids hold the largest share of the mouth ulcer treatment industry due to their powerful anti-inflammatory and immunosuppressive properties. These medications effectively reduce swelling, pain, and irritation associated with mouth ulcers, promoting faster healing. Corticosteroids are often prescribed for severe or recurrent cases of ulcers, such as aphthous stomatitis, where over-the-counter treatments may be less effective. Their ability to target the underlying inflammation makes them a preferred choice among healthcare professionals. Additionally, advancements in topical corticosteroid formulations, like gels and ointments, have improved patient compliance by offering localized relief with minimal systemic side effects. These factors are creating a positive mouth ulcer treatment market outlook, driving the demand for corticosteroid-based products due to their efficacy in managing severe ulcer cases.
Aphthous Stomatitis represents the leading market segment
Aphthous stomatitis, commonly known as canker sores, represents the leading segment in the mouth ulcer treatment market due to its high prevalence among individuals worldwide. This condition is characterized by recurrent, painful ulcers in the mouth, often triggered by stress, injury, or nutritional deficiencies. The demand for effective treatments, such as corticosteroids, gels, and antiseptic mouthwashes, is high as patients seek fast relief from discomfort and accelerated healing. The chronic and recurrent nature of aphthous stomatitis drives the consistent demand for both over-the-counter and prescription treatments. The mouth ulcer treatment market dynamics are further influenced by the need for innovative and accessible solutions to manage the chronic and recurrent nature of aphthous stomatitis, leading to continuous advancements in treatment options and increased competition among pharmaceutical companies. According to an article published in May 2023 by National Library of Medicine, approximately 25% of the global population is affected by recurrent aphthous stomatitis (RAS), a common oral mucosal disease. Factors such as genetics, nutritional deficiencies, stress, and immune dysfunction contribute to the condition. This high prevalence underscores the significant demand for effective treatments and preventive solutions in the market. As a result, pharmaceutical companies are focusing on developing targeted therapies that address the underlying causes of RAS while minimizing recurrence and improving patient outcomes.
North America leads the market, accounting for the largest mouth ulcer treatment market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, Latin America. According to the report, North America represents the largest regional market for mouth ulcer treatment.
North America leads the global mouth ulcer treatment market, accounting for the largest share due to the region's high awareness of oral health and access to advanced healthcare services. The prevalence of conditions like aphthous stomatitis and other oral ulcers is significant, driving the demand for both over-the-counter and prescription treatments. The region's well-established pharmaceutical industry supports the development and availability of effective treatments, such as corticosteroids, gels, and mouthwashes. Additionally, the focus on research and innovation, along with favorable healthcare reimbursement policies, boosts market growth. The increasing preference for fast-acting, pain-relief products further strengthens North America's leadership in this market. According to mouth ulcer treatment market forecast, North America is expected to continue to lead, with steady growth driven by ongoing advancements in treatment options, rising demand for innovative therapies, and increasing awareness of oral health management. For instance, in November 2023, MidAmerica Pharmaceuticals introduced Kourzeq(TM), a new FDA-approved dental paste for treating canker sores. The paste, containing triamcinolone acetonide, is designed to provide temporary relief and adjunctive treatment for oral inflammatory and ulcerative lesions. Available exclusively through telehealth via BeyondMD, Kourzeq aims to make a positive impact on those suffering from canker sores.